Entero Healthcare Solutions growth ratios

·Consumer ServicesChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024
+29.3%+29.9%—
+55.0%+53.4%—
+58.1%+62.2%—
+35.7%+169.9%—
+21.3%+101.7%—
+33.2%+15.2%+79.2%
−1.0%+7.9%+174.6%
+225.2%−109.9%—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ENTERO₹1,559.30

Entero Healthcare Solutions Ltd.

· Consumer Services
₹ CrorePeersMEDPLUSEMILCRIZACGPPLCMSINFOHEMIPROPBLACKBUCKINOXGREENMcap ₹6,785 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth——+29.9+29.3—
EBITDA Growth——+53.4+55.0—
EBIT Growth——+62.2+58.1—
Net Income Growth——+169.9+35.7—
EPS Growth——+101.7+21.3—
Total Assets Growth—+79.2+15.2+33.2—
Total Equity Growth—+174.6+7.9-1.0—
Cash from Operations Growth——-109.9+225.2—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.